The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA.

Source:http://linkedlifedata.com/resource/pubmed/id/19965647

Blood 2010 Feb 4 115 5 948-56

Download in:

View as

General Info

PMID
19965647